Farquharson Andrew
SEC insider (Form 3/4/5 filer). CIK 0001865699. Director at Rani Therapeutics Holdings, Inc. (RANI). 3 reported Form 4/5 transactions since Sep 2024; latest on May 28, 2025. Located in SAN JOSE, CA.
Companies Farquharson Andrew has filed insider reports for
- Rani Therapeutics Holdings, Inc. (RANI): Director
Farquharson Andrew
CIK: 0001865699
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Rani Therapeutics Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- May 28, 2025RANI
Rani Therapeutics Holdings, Inc.
AwardDirectDirector Stock Option (Right to Buy)
50K shares- - Dec 16, 2024RANI
Rani Therapeutics Holdings, Inc.
DispositionDirectStock Option (Right to Buy)
101.3K shares- - Dec 16, 2024RANI
Rani Therapeutics Holdings, Inc.
AwardDirectStock Option (Right to Buy)
101.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 28, 2025 | RANI Rani Therapeutics Holdings, Inc. | Award Director Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Dec 16, 2024 | RANI Rani Therapeutics Holdings, Inc. | Disposition Stock Option (Right to Buy) | 101,276 | - | - | Direct |
| Dec 16, 2024 | RANI Rani Therapeutics Holdings, Inc. | Award Stock Option (Right to Buy) | 101,276 | - | - | Direct |
1-3 of 3 transactions